Marie A. Vodicka

ID: 1b83408f-2619-30fb-68c4

/

Unclaimed

/

Organization: Hogan Lovells

Awaiting FDA Guidance on Interchangeability for Biosimilars

Biosimilars Law Blog · March 22, 2012

EMA regulatory approval changes for biosimilars on the horizon in the E.U.?

Biosimilars Law Blog · February 8, 2012

Biosimilars, biosimilarity—what does ‘highly similar’ mean?

Biosimilars Law Blog · February 1, 2012

Why are generic drugs the ‘same’ and biosimilars only ‘similar’ to their corresponding reference products?

Biosimilars Law Blog · January 25, 2012

Global Dis-Harmonization of Biosimilar Naming and Labeling

Biosimilars Law Blog · January 18, 2012